Beacon Pointe Advisors, LLC Takeda Pharmaceutical CO LTD Transaction History

Beacon Pointe Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$15.03 - $16.32 $8,792 - $9,547	585 Added 5.15%	11,950 $184,000
Q2 2023 Aug 11, 2023	SELL	$15.57 - $17.11 $22,654 - $24,895	-1,455 Reduced 11.35%	11,365 $178,000
Q1 2023 May 12, 2023	BUY	$15.28 - $16.48 $14,928 - $16,100	977 Added 8.25%	12,820 $211,000
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $147,090 - $184,987	11,843 New	11,843 $184,000
Q2 2022 Aug 11, 2022	BUY	$13.12 - $15.03 $2,125 - $2,434	162 Added 1.37%	12,023 $169,000
Q1 2022 May 17, 2022	BUY	$13.54 - $15.35 $16,112 - $18,266	1,190 Added 11.15%	11,861 $170,000
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $140,537 - $175,004	10,671 New	10,671 $145,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.